Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation

Lorentino, F; Xue, ELSBT; Mastaglio, S; Giglio, F; Clerici, D; Farina, F; Piemontese, S; Bruno, A; Lazzari, L; Ruggeri, A; Guggiari, E; Lunghi, F; Assanelli, AA; Marktel, S; Marcatti, M; Carrabba, MG; Bernardi, M; Corti, C; Peccatori, J; Ciceri, F; Greco, R; Lupo-Stanghellini, MT

Lorentino, F; Xue, ELSBT (通讯作者),IRCCS San Raffaele Sci Inst, Hematol & Bone Marrow Transplantat Unit, Milan, Italy.

BLOOD ADVANCES, 2022; 6 (10): 3053

Abstract

Among major unmet needs in allogeneic stem cell transplantation (HSCT), the identification of a suitable donor, the control of infection complications......

Full Text Link